Outcome of Ivermectin Treated Mild to Moderate COVID-19 Cases: A Single-Centre, Open-Label, Randomised Controlled Study. IMC J Med Sci 2021, 14 (2), 11-18. https://doi.org/10.3329/imcjms.v14i2.52826.